首页 > 最新文献

Nature Reviews Clinical Oncology最新文献

英文 中文
From the ESMO Congress 2025 来自2025年ESMO大会
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-11-04 DOI: 10.1038/s41571-025-01101-2
Diana Romero
{"title":"From the ESMO Congress 2025","authors":"Diana Romero","doi":"10.1038/s41571-025-01101-2","DOIUrl":"10.1038/s41571-025-01101-2","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"23 1","pages":"1-1"},"PeriodicalIF":82.2,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145440875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervening on dormancy to prevent breast cancer recurrence 干预休眠以防止乳腺癌复发
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-11-03 DOI: 10.1038/s41571-025-01087-x
Tanja Fehm, Hans Neubauer
Dormant tumour cells that survive initial therapy can awaken years later to seed metastases. New data from a phase II trial indicate that intercepting this dormancy by targeting autophagy and mTOR signalling might prevent breast cancer relapse before it begins, opening a path towards proactive prevention disease recurrence.
在初始治疗中存活下来的休眠肿瘤细胞可能在数年后被唤醒,形成转移的种子。来自一项II期试验的新数据表明,通过靶向自噬和mTOR信号传导来阻断这种休眠可能会在乳腺癌开始之前阻止其复发,从而为主动预防疾病复发开辟了一条道路。
{"title":"Intervening on dormancy to prevent breast cancer recurrence","authors":"Tanja Fehm, Hans Neubauer","doi":"10.1038/s41571-025-01087-x","DOIUrl":"10.1038/s41571-025-01087-x","url":null,"abstract":"Dormant tumour cells that survive initial therapy can awaken years later to seed metastases. New data from a phase II trial indicate that intercepting this dormancy by targeting autophagy and mTOR signalling might prevent breast cancer relapse before it begins, opening a path towards proactive prevention disease recurrence.","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"23 1","pages":"5-6"},"PeriodicalIF":82.2,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145427419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Domvanalimab plus zimberelimab shows promise in upper-tract cancers Domvanalimab和zimberelimab联合治疗上呼吸道癌症
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-31 DOI: 10.1038/s41571-025-01097-9
Peter Sidaway
{"title":"Domvanalimab plus zimberelimab shows promise in upper-tract cancers","authors":"Peter Sidaway","doi":"10.1038/s41571-025-01097-9","DOIUrl":"10.1038/s41571-025-01097-9","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"23 1","pages":"2-2"},"PeriodicalIF":82.2,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145405032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative therapy effective in high-risk HCC 围手术期治疗对高危HCC有效
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-31 DOI: 10.1038/s41571-025-01091-1
Peter Sidaway
{"title":"Perioperative therapy effective in high-risk HCC","authors":"Peter Sidaway","doi":"10.1038/s41571-025-01091-1","DOIUrl":"10.1038/s41571-025-01091-1","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"22 12","pages":"899-899"},"PeriodicalIF":82.2,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145404657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frontline sacituzumab govitecan prolongs PFS in TNBC 一线sacituzumab govitecan延长TNBC患者的PFS。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-28 DOI: 10.1038/s41571-025-01093-z
David Killock
{"title":"Frontline sacituzumab govitecan prolongs PFS in TNBC","authors":"David Killock","doi":"10.1038/s41571-025-01093-z","DOIUrl":"10.1038/s41571-025-01093-z","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"23 1","pages":"2-2"},"PeriodicalIF":82.2,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145381056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iza-bren shows promise in recurrent or metastatic nasopharyngeal carcinoma Iza-bren在复发或转移性鼻咽癌中显示出希望。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-28 DOI: 10.1038/s41571-025-01094-y
Diana Romero
{"title":"Iza-bren shows promise in recurrent or metastatic nasopharyngeal carcinoma","authors":"Diana Romero","doi":"10.1038/s41571-025-01094-y","DOIUrl":"10.1038/s41571-025-01094-y","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"23 1","pages":"2-2"},"PeriodicalIF":82.2,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145381081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination neoadjuvant chemotherapy improves outcomes 联合新辅助化疗可改善预后。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-27 DOI: 10.1038/s41571-025-01086-y
Peter Sidaway
{"title":"Combination neoadjuvant chemotherapy improves outcomes","authors":"Peter Sidaway","doi":"10.1038/s41571-025-01086-y","DOIUrl":"10.1038/s41571-025-01086-y","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"22 12","pages":"898-898"},"PeriodicalIF":82.2,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145377930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ivonescimab delays disease progression Ivonescimab延缓疾病进展。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-27 DOI: 10.1038/s41571-025-01088-w
Peter Sidaway
{"title":"Ivonescimab delays disease progression","authors":"Peter Sidaway","doi":"10.1038/s41571-025-01088-w","DOIUrl":"10.1038/s41571-025-01088-w","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"22 12","pages":"898-898"},"PeriodicalIF":82.2,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145377888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HER2-directed therapy improves urothelial cancer outcomes her2定向治疗可改善尿路上皮癌的预后。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-27 DOI: 10.1038/s41571-025-01089-9
David Killock
{"title":"HER2-directed therapy improves urothelial cancer outcomes","authors":"David Killock","doi":"10.1038/s41571-025-01089-9","DOIUrl":"10.1038/s41571-025-01089-9","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"22 12","pages":"898-898"},"PeriodicalIF":82.2,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belzutifan as a new option in pheochromocytomas and paragangliomas Belzutifan作为嗜铬细胞瘤和副神经节瘤的新选择。
IF 82.2 1区 医学 Q1 ONCOLOGY Pub Date : 2025-10-27 DOI: 10.1038/s41571-025-01092-0
Diana Romero
{"title":"Belzutifan as a new option in pheochromocytomas and paragangliomas","authors":"Diana Romero","doi":"10.1038/s41571-025-01092-0","DOIUrl":"10.1038/s41571-025-01092-0","url":null,"abstract":"","PeriodicalId":19079,"journal":{"name":"Nature Reviews Clinical Oncology","volume":"22 12","pages":"899-899"},"PeriodicalIF":82.2,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nature Reviews Clinical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1